Bibliografisk träff 2023-06-07 Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease. Bhatnagar A, Parmar V, Barbieri N, Bearoff F, Elefant F, Kortagere S. Front Behav Neurosci · research-article; journal article · DOI 10.3389/fnbeh.2023.1176777